Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1970 1
1977 1
1979 1
1981 1
1989 1
1994 1
1997 1
2000 1
2002 2
2003 2
2004 4
2005 3
2006 5
2007 6
2008 1
2009 2
2010 3
2011 3
2012 1
2013 1
2014 3
2015 2
2016 7
2017 6
2018 6
2019 7
2020 12
2021 14
2022 9
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for pietro acetic
Search for Pietro Aceti instead (2 results)
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Hirschfield GM, et al. Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
A Comprehensive Review on Copemyl®.
Annovazzi P, Bertolotto A, Brescia Morra V, Gasperini C, Montanari E, Navarra P, Patti F, Sormani MP, Ghezzi A. Annovazzi P, et al. Neurol Ther. 2017 Dec;6(2):161-173. doi: 10.1007/s40120-017-0079-3. Epub 2017 Jul 31. Neurol Ther. 2017. PMID: 28762192 Free PMC article. Review.
Glatiramoids are a class of drugs whose forefather, glatiramer acetate, has been used as a disease modifying drug (DMD) in patients with MS for over 20 years. ...
Glatiramoids are a class of drugs whose forefather, glatiramer acetate, has been used as a disease modifying drug (DMD) in patients w …
Fruits Vinegar: Quality Characteristics, Phytochemistry, and Functionality.
Ousaaid D, Mechchate H, Laaroussi H, Hano C, Bakour M, El Ghouizi A, Conte R, Lyoussi B, El Arabi I. Ousaaid D, et al. Molecules. 2021 Dec 30;27(1):222. doi: 10.3390/molecules27010222. Molecules. 2021. PMID: 35011451 Free PMC article. Review.
It contains a cocktail of bioactive ingredients including polyphenolic acids, organic acids, tetramethylperazine, and melanoidins. Acetic acid is the most abundant organic acid and chlorogenic acid is the major phenol in apple vinegar. ...
It contains a cocktail of bioactive ingredients including polyphenolic acids, organic acids, tetramethylperazine, and melanoidins. Acetic …
Olfactory-hypoglossal connections.
Mameli O, Russo A, Borke R, Melis F, Caria MA, Pellitteri R, Tavera C, Stanzani S. Mameli O, et al. Pflugers Arch. 2003 Mar;445(6):705-15. doi: 10.1007/s00424-002-0977-8. Epub 2003 Jan 18. Pflugers Arch. 2003. PMID: 12632191
Natural olfactory stimulation with amyl acetate significantly modulates the electrical activity of hypoglossal neurons and the electromyographic responses of the tongue musculature. ...
Natural olfactory stimulation with amyl acetate significantly modulates the electrical activity of hypoglossal neurons and the electr …
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.
Iaffaldano P, Lucisano G, Caputo F, Paolicelli D, Patti F, Zaffaroni M, Brescia Morra V, Pozzilli C, De Luca G, Inglese M, Salemi G, Maniscalco GT, Cocco E, Sola P, Lus G, Conte A, Amato MP, Granella F, Gasperini C, Bellantonio P, Totaro R, Rovaris M, Salvetti M, Torri Clerici VLA, Bergamaschi R, Maimone D, Scarpini E, Capobianco M, Comi G, Filippi M, Trojano M; Italian MS Register. Iaffaldano P, et al. Ther Adv Neurol Disord. 2021 May 31;14:17562864211019574. doi: 10.1177/17562864211019574. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 34104220 Free PMC article.
ESC group patients received the high efficacy DMT after 1 year of glatiramer acetate, interferons, azathioprine, teriflunomide or dimethylfumarate treatment. ...
ESC group patients received the high efficacy DMT after 1 year of glatiramer acetate, interferons, azathioprine, teriflunomide or dim …
A real-world study of alemtuzumab in a cohort of Italian patients.
Russo CV, Saccà F, Frau J, Annovazzi P, Signoriello E, Bonavita S, Grasso R, Clerico M, Cordioli C, Laroni A, Capobianco M, Torri Clerici V, Sartori A, Cavalla P, Maniscalco GT, La Gioia S, Caleri F, Giugno A, Iodice R, Carotenuto A, Cocco E, Fenu G, Zaffaroni M, Baroncini D, Lus G, Gallo A, De Mercanti SF, Lapucci C, Di Francescantonio V, Brambilla L, Sormani MP, Signori A. Russo CV, et al. Eur J Neurol. 2022 Jan;29(1):257-266. doi: 10.1111/ene.15121. Epub 2021 Oct 5. Eur J Neurol. 2022. PMID: 34558755 Free PMC article.
Previous treatments were: fingolimod (106), natalizumab (80), first-line oral agents (56), first-line injectables (interferon/glatiramer acetate; 30), and other drugs (15). Thirty-five patients were treatment-naive. ...
Previous treatments were: fingolimod (106), natalizumab (80), first-line oral agents (56), first-line injectables (interferon/glatiramer …
Effect of teriflunomide on QuantiFERON-TB Gold results.
Bua A, Ruggeri M, Zanetti S, Molicotti P. Bua A, et al. Med Microbiol Immunol. 2017 Feb;206(1):73-75. doi: 10.1007/s00430-016-0482-x. Epub 2016 Oct 4. Med Microbiol Immunol. 2017. PMID: 27704206
There is still no curative treatment, but during the last 20 years eight different therapies have become available including interferon beta, glatiramer acetate, teriflunomide, dimethyl fumarate, natalizumab, fingolimod, alemtuzumab, mitoxantrone and teriflunomide. ...
There is still no curative treatment, but during the last 20 years eight different therapies have become available including interferon beta …
N-Heterocyclic Carbene (NHC) Silver Complexes as Versatile Chemotherapeutic Agents Targeting Human Topoisomerases and Actin.
Mariconda A, Iacopetta D, Sirignano M, Ceramella J, Costabile C, Pellegrino M, Rosano C, Catalano A, Saturnino C, El-Kashef H, Aquaro S, Sinicropi MS, Longo P. Mariconda A, et al. ChemMedChem. 2022 Sep 16;17(18):e202200345. doi: 10.1002/cmdc.202200345. Epub 2022 Aug 17. ChemMedChem. 2022. PMID: 35904129 Free PMC article.
In our study, we designed and synthesized a new series of silver N-heterocyclic carbene (NHC) complexes [(NHC)(2) Ag](+) [AgX(2) ](-) (X=iodide or acetate). The new complexes were active against two human breast cancer cell lines, MCF-7 and MDA-MB-231. ...
In our study, we designed and synthesized a new series of silver N-heterocyclic carbene (NHC) complexes [(NHC)(2) Ag](+) [AgX(2) ](-) (X=iod …
107 results